Page 2175 - Williams Hematology ( PDFDrive )

2150 Part XII: Hemostasis and Thrombosis <CN>: <CT> PB

293. Board PG, Webb GC, McKee J, Ichinose A: Localization of the coagulation factor XIII 311. Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A: Factor XIII A subunit-deficient
A subunit gene (F13A) to chromosome bands 6p24-p25. Cytogenet Cell Genet 48:25, mice developed severe uterine bleeding events and; subsequent spontaneous miscar-
1988. riages. Blood 102:4410, 2003.
294. Weisberg LJ, Shiu DT, Greenberg CS, et al: Localization of the gene for coagulation fac- 312. Lauer P, Metzner HJ, Zettlmeissl G, et al: Targeted inactivation of the mouse locus
tor XIII a-chain to chromosome 6, and identification of sites of synthesis. J Clin Invest encoding coagulation factor XIIIA: Hemostatic abnormalities in mutant mice and char-
79:649, 1987. acterization of the coagulation deficit. Thromb Haemost 88:967, 2002.
295. Ichinose A, Davie EW: Characterization of the gene for the a subunit of human factor 313. Souri M, Koseki-Kuno S, Takeda N, et al: Male specific cardiac pathologies in mice
XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci U S A lacking either the A or B subunit of factor XIII. Thromb Haemost 99:401, 2008.
85:5829, 1988. 314. Dreyfus M, Barrois D, Borg JY, et al: Successful long-term replacement therapy with
296. Webb GC, Coggan M, Ichinose A, Board PG: Localization of the coagulation factor FXIII concentrate (Fibrogammin1 P) for severe congenital factor XIII deficiency: A
XIII B subunit gene (F13B) to chromosome bands 1q31–32.1, and restriction fragment prospective multicentre study. J Thromb Haemost 9:1264, 2011.
length polymorphism at the locus. Hum Genet 81:157, 1989. 315. Gootenberg JE: Factor concentrates for the treatment of factor XIII deficiency. Curr
297. Bottenus RE, Ichinose A, Davie EW: Nucleotide sequence of the gene for the b subunit Opin Hematol 5:372, 1998.
of human factor XIII. Biochemistry 29:11195, 1990. 316. Odame JE, Chan AK, Wu JK, Breakey VR: Factor XIII deficiency management: A
298. Biswas A, Ivaskevicius V, Seitz R, et al: An update of the mutation profile of Factor 13A review of the literature. Blood Coagul Fibrinolysis 25:199, 2014.
and B genes. Blood Rev 25:193, 2011. 317. Dorey E: First recombinant Factor XIII approved. Nat Biotechnol 32:210, 2014.
299. Morange P, Trigui N, Frere C, et al: Molecular characterization of a novel mutation in 318. Furie B, Voo L, McAdam KP, Furie BC: Mechanism of factor X deficiency in systemic
the factor XIII a subunit gene associated with a severe defect: Importance of prophylac- amyloidosis. N Engl J Med 304:827, 1981.
tic substitution. Blood Coagul Fibrinolysis 20:605, 2009. 319. Fair DS, Edgington TS: Heterogeneity of hereditary and acquired factor X deficiencies
300. Inbal A, Yee VC, Kornbrot N, et al: Factor XIII deficiency due to a Leu660Pro mutation by combined immunochemical and functional analyses. Br J Haematol 59:235, 1985.
in the factor XIII subunit-A gene in three unrelated Palestinian Arab families. Thromb 320. Bajaj SP, Rapaport SI, Fierer DS, et al: A mechanism for the hypoprothrombinemia
Haemost 77:1062, 1997 of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 61:684,
301. Mikkola H, Syrjala M, Rasi V, et al: Deficiency in the A-subunit of coagulation factor 1983.
XIII: Two novel point mutations demonstrate different effects on transcript level. Blood 321. Lim S, Zuha R, Burt T, et al: Life-threatening bleeding in a patient with a lupus inhibitor
84:517, 1994. and probable acquired factor VII deficiency. Blood Coagul Fibrinolysis 17:867, 2006.
302. Schroeder V, Durrer D, Meili E, et al: Congenital factor XIII deficiency in Switzerland: 322. Wiwanitkit V: Spectrum of bleeding in acquired factor V inhibitor: A summary of 33
From the worldwide first case in 1960, to its molecular characterisation in 2005. Swiss cases. Clin Appl Thromb Hemost 12:485, 2006.
Med Wkly 137:272, 2007. 323. Rao LV, Zivelin A, Iturbe I, Rapaport SI: Antibody-induced acute factor X deficiency:
303. Aslam S, Standen GR, Khurshid M, Bilwani F: Molecular analysis of six factor Clinical manifestations and properties of the antibody. Thromb Haemost 72:363, 1994.
XIII-A-deficient families in Southern Pakistan. Br J Haematol 109:463, 2000. 324. Mulhare PE, Tracy PB, Golden EA, et al: A case of acquired factor X deficiency with
304. Hsieha L, Nugent D: Rare factor deficiencies. Curr Opin Hematol 19:380, 2012. in vivo and in vitro evidence of inhibitor activity directed against factor X. Am J Clin
305. Karimi M, Bereczky Z, Cohan N, Muszbek L: Factor XIII deficiency. Semin Thromb Pathol 96:196, 1991.
Hemost 35:426, 2009. 325. Matsunaga AT, Shafer FE: An acquired inhibitor to factor X in a pediatric patient with
306. Dardik R, Loscalzo J, Inbal A: Factor XIII (FXIII) and angiogenesis. J Thromb Haemost extensive burns. J Pediatr Hematol Oncol 18:223, 1996.
4:19, 2006. 326. Gallais V, Bredoux H, leRoux G, Laroche L: Acquired and transient factor X deficiency
307. Sharief LAT, Kadir RA: Congenital factor XIII deficiency in women: A systematic associated with sodium valproate treatment. Eur J Haematol 57:330, 1996.
review of literature. Haemophilia 19:e349, 2013. 327. Lankiewicz MW, Bell WR: A unique circulating inhibitor with specificity for coagula-
308. Asahina T, Kobayashi T, Okada Y, et al: Maternal blood coagulation factor XIII is asso- tion factor X. Am J Med 93:343, 1992.
ciated with the development of cytotrophoblastic shell. Placenta 21:388, 2000. 328. Ichinose A, Souri M: Japanese Collaborative Research Group on Acquired Haem-
309. Inbal A, Muszbek L: Coagulation factor deficiencies and pregnancy loss. Semin Thromb orrhaphilia Due to Factor XIII Deficiency: As many as 12 cases with haemorrhagic
Hemost 29:171, 2003. acquired factor XIII deficiency due to its inhibitors were recently found in Japan.
310. Mahmoodi M, Peyvandi F, Afrasiabi A, et al: Bleeding symptoms in heterozygous Thromb Haemost 105:925, 2011.
carriers of inherited coagulation disorders in southern Iran. Blood Coagul Fibrinolysis 329. Ichinose A: Factor XIII as a key molecule at the intersection of coagulation and
22:396, 2011. fibrinolysis as well as inflammation and infection control. Int J Hematol 95:362, 2012.

Kaushansky_chapter 124_p2133-2150.indd 2150 17/09/15 3:43 pm